This helps us connect you with a licensed provider in your state.
Lose up to 20% of your weight
On average, people lost 15–20% of their body weight in a 68-week clinical trial study of
Wegovy®*
Graph for illustrative purposes only to demonstrate potential appetite
suppression trends. Individual results will vary. *Along with a reduced calorie diet and
increased exercise. In a 68-week clinical study of Wegovy®, about 1 in 3 adults with obesity or
with overweight and weight-related medical problems achieved 20% weight loss. Average weight
loss achieved was 15%. Wegovy®is a registered trademark of Novo Nordisk A/S.
Choose your medication
Select an option that works best for you.
COMPOUNDED
$449 first month
Tirzepatide
The same active ingredient in the brand name medications.
Regular pricing ($249/month) resumes on second month.
Choose your membership
Select an option that works best for you.
*This subscription will renew automatically unless canceled, and
by
selecting a long-term contract, you commit to the full term.
×
Change your membership
6-month contract
$267/month*
Subscribe to save $180 on a long-term program for continued
12-month contract
$247/month*
Subscribe to save $180 on a long-term program for continued
Month-to-month
$297/month
Flexible program to support your weight loss journey.
*Month-to-month and Subscribe To Save memberships will automatically renew for the selected
contract term unless canceled. By selecting a Subscribe To Save membership, you agree to Trinity Meds
Multi-Month Pricing Program Terms of Service.
